BEDFORD, Mass., Sept. 16, 2015 /PRNewswire/ -- Hologic, Inc.
(NASDAQ: HOLX) announced today that U.S. mammography providers gave
Hologic and Hologic's Genius™ 3D Mammography™ exams top
scores in a new study by KLAS Research, Women's Imaging 2015.
Are New Technologies Delivering Promised Benefits?
1
In the study, mammography providers scored Hologic highest in
all 11 performance measures evaluated by KLAS. For
example:
- 95% of users said they would buy from Hologic again.
- 67% of users said Hologic was their best mammography
vendor.
The researchers noted that Hologic 3D
Mammography™ stands out for technology
innovation and high image quality, and that its C-View™
software is strengthening satisfaction and encouraging
adoption.
"For many years, Hologic's mammography systems have been the
systems of choice in most countries of the world," said
Pete Valenti, Hologic's Division
President, Breast and Skeletal Health Solutions. "This new study
shows that Hologic continues to lead the U.S. breast cancer
screening market, and that customers are pleased with our
Genius™ 3D Mammography™ exams."
The KLAS study found significant movement in the mammography
space thanks to the advent of breast tomosynthesis technology. For
example, 65% of the providers surveyed by KLAS planned to invest in
breast tomosynthesis technology during the next two years, up from
57% in 2014. The study notes that many respondents who said they
did not intend to purchase had already upgraded to
tomosynthesis.
Clinical studies have shown that a Hologic Genius™ 3D
Mammography™ exam using the Company's low-dose software is
superior to 2D exams alone for all breast types, improving
diagnostic accuracy while also reducing recalls. With C-View™
software, facilities can offer a better exam at an equivalent dose
to 2D alone.
A site locator for Genius™ 3D Mammography™ exams is
available by clicking on
http://mygenius3d.com/find-a-facility/. Genius™ 3D
Mammography™ exams are available only on Hologic's
Selenia® Dimensions® system.
1 "Women's Imaging. Are the New Technologies
Delivering Promised Benefits? August
2015. Performance Report." © 2015 KLAS Enterprises, LLC. All
rights reserved. www.KLASresearch.com
About KLAS Research
KLAS is a healthcare technology research firm that specializes
in monitoring and reporting the performance of software, services,
medical equipment, and infrastructure vendors. Working with
thousands of healthcare executives from hospitals and clinics
worldwide, KLAS collects performance feedback to deliver timely
reports, trends, and statistics that provide a solid overview of
vendor performance in the industry.
About Hologic
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems and
surgical products. The Company's core business units focus on
diagnostics, breast health, GYN surgical, and skeletal health. With
a unified suite of technologies and a robust research and
development program, Hologic is dedicated to The Science of Sure.
For more information on Hologic, visit www.hologic.com.
Hologic, 3D Mammography, C-View, Dimensions, Genius, Science of
Sure, and Selenia are trademarks and/or registered trademarks of
Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic digital mammography systems. There can be no
assurance the systems will achieve the benefits described here, or
that such benefits will be replicated in any particular manner with
respect to an individual patient. The actual effect of the use of
the systems can only be determined on a case-by-case basis
depending on the particular circumstances and patient in question.
Hologic expressly disclaims any obligation to release publicly any
updates to the data or statements presented here to reflect any
change in the Company's expectations or any change in events,
conditions or circumstances on which any such data or statements
are based.
Contacts:
Media
Jim
Culley, PhD
Senior Director, Corporate
Communications
781-999-7583
jim.culley@hologic.com
Investors
Michael Watts
Vice President, Investor Relations and Corporate Communications
858-410-8588
michael.watts@hologic.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hologics-genius-3d-mammography-continues-to-lead-the-us-breast-tomosynthesis-market-klas-research-reports-300143619.html
SOURCE Hologic, Inc.